Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Cited by (924)

Items 301–400 of 924

1. Cytoplasmic dynein: a key player in neurodegenerative and neurodevelopmental diseases
   Xiangjun Chen, Huan Xu, Helen M. Cooper, Yaobo Liu · 2014 · Science China Life Sciences
2. Oxidation of the Tryptophan 32 Residue of Human Superoxide Dismutase 1 Caused by Its Bicarbonate-dependent Peroxidase Activity Triggers the Non-amyloid Aggregation of the Enzyme
   Fernando Rodrigues Coelho, Asif Iqbal, Edlaine Linares, Daniel F. Silva, Filipe S. Lima, Iolanda Midea Cuccovia, Ohára Augusto · 2014 · Journal of Biological Chemistry
3. The secret life of extracellular vesicles in metal homeostasis and neurodegeneration
   Shayne A. Bellingham, Belinda B. Guo, Andrew Francis Hill · 2015 · Biology of the Cell
4. Update on the role of p75NTR in neurological disorders: A novel therapeutic target
   Ya-Hai Shu, Xiu‐Min Lu, Jing-Xiang Wei, Lan Xiao, Yong‐Tang Wang · 2015 · Biomedicine & Pharmacotherapy
5. Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver Injury
   Yifan Bao, Xiaochao Ma, Theodore P. Rasmussen, Xiao‐bo Zhong · 2018 · Current Pharmacology Reports
6. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
   Zichun Zhao, Jinsheng Fu, Shiping Li, Zhenzhong Li · 2019 · Journal of Neuroimmune Pharmacology
7. Promoter-Associated Noncoding RNA from the CCND1 Promoter
   Xiaoyuan Song, Xiangting Wang, Shigeki Arai, Riki Kurokawa · 2011 · Methods in molecular biology
8. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases
   Elke Bogaert, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht · 2006 · Muscle & Nerve
9. Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis
   Stefanie Rauskolb, Benjamin Dombert, Michael Sendtner · 2016 · Neurobiology of Disease
10. Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets
    Giovanna Morello, Antonio Gianmaria Spampinato, Sebastiano Cavallaro · 2017 · Mediators of Inflammation
11. Gut microbiome and amyotrophic lateral sclerosis: a systematic review of current evidence
    Sun, Jiangwei, Huang, Tingting, Debelius, Justine W., Fang, Fang · 2021 · Journal of Internal Medicine
12. Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration
    Sebastian A. Lewandowski, Ingrid Nilsson, Linda Fredriksson, Peter Lönnerberg, Lars Muhl, Manuel Zeitelhofer, Milena Z. Adzemovic, Susanne Nichterwitz, Daniel A. Lawrence, Eva Hedlund et al. · 2015 · Acta Neuropathologica
13. UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis
    Katerina Placek, G. Michael Baer, Lauren B. Elman, Leo F. McCluskey, Laura Hennessy, Pilar M. Ferraro, Edward B. Lee, Virginia M.‐Y. Lee, John Q. Trojanowski, Vivianna M. Van Deerlin et al. · 2018 · Neurobiology of Aging
14. When Does ALS Start? ADAR2?GluA2 Hypothesis for the Etiology of Sporadic ALS
    Takuto Hideyama, Shin Kwak · 2011 · Frontiers in Molecular Neuroscience
15. The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis
    Di He, Yan Chun Xu, Mingsheng Liu, Liying Cui · 2023 · Aging and Disease
16. Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis
    Yongping Chen, Rui Huang, Yuan Yang, Ke Chen, Wei Song, PingLei Pan, JianPeng Li, Huifang Shang · 2011 · Neurobiology of Aging
17. Microglial Keratan Sulfate Epitope Elicits in Central Nervous Tissues of Transgenic Model Mice and Patients with Amyotrophic Lateral Sclerosis
    Tahmina Foyez, Yoshiko Takeda‐Uchimura, Shinsuke Ishigaki, Narentuya, Zui Zhang, Gen Sobue, Kenji Kadomatsu, Kenji Uchimura · 2015 · American Journal Of Pathology
18. Ultrastructural studies of ALS mitochondria connect altered function and permeability with defects of mitophagy and mitochondriogenesis
    Riccardo Ruffoli, Alessia Bartalucci, Alessandro Frati, Francesco Fornai · 2015 · Frontiers in Cellular Neuroscience
19. Progressive motor unit loss in the G93A mouse model of amyotrophic lateral sclerosis is unaffected by gender
    Janka Hegedus, Charles T. Putman, Tessa Gordon · 2009 · Muscle & Nerve
20. Differentiating human stem cells into neurons and glial cells for neural repair
    Vimal Selvaraj · 2011 · Frontiers in bioscience
21. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
    Marta Łukaszewicz‐Zając, Barbara Mroczko, Agnieszka Słowik · 2014 · Journal of Neural Transmission
22. Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons
    Disi An, Ryosuke Fujiki, Dylan E. Iannitelli, John W. Smerdon, Shuvadeep Maity, Matthew F. Rose, Alon Gelber, Elizabeth K. Wanaselja, Ilona Yagudayeva, Joun Y. Lee et al. · 2019 · eLife
23. Molecular Mechanisms in Amyotrophic Lateral Sclerosis: The Role of Angiogenin, a Secreted RNase
    Isabela M. Aparicio, Jochen H.M. Prehn · 2012 · Frontiers in Neuroscience
24. Deletions Causing Spinal Muscular Atrophy Do Not Predispose to Amyotrophic Lateral Sclerosis
    Jillian S. Parboosingh, Vincent Meininger, Diane M. McKenna-Yasek, Robert H. Brown, Guy Armand Rouleau · 1999 · Archives of Neurology
25. Primary Cilia in Glial Cells: An Oasis in the Journey to Overcoming Neurodegenerative Diseases
    Soo Mi Ki, Hui Su Jeong, Ji Eun Lee · 2021 · Frontiers in Neuroscience
26. In vivo detection of free radicals using molecular MRI and immuno-spin trapping in a mouse model for amyotrophic lateral sclerosis
    Rheal A. Towner, Nataliya Smith, Debra Saunders, Florea Lupu, Robert Silasi‐Mansat, Melinda S. West, Darío C. Ramírez, Sandra Gomez-Mejiba, Marcelo Gialluisi Bonini, Ronald Paul Mason et al. · 2013 · Free Radical Biology and Medicine
27. Angiogenin induces modifications in the astrocyte secretome: Relevance to amyotrophic lateral sclerosis
    Alexandra Skorupa, Serge Urbach, Oana Vigy, Matthew A. King, Séverine Chaumont‐Dubel, Jochen H.M. Prehn, Philippe Marin · 2013 · Journal of Proteomics
28. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases
    Natalie L. Payne, Aude Sylvain, Carmel O’Brien, Daniella Herszfeld, Guizhi Sun, Claude C.A. Bernard · 2014 · New Biotechnology
29. Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis
    Tessa Gordon, Neil Tyreman, S. Li, Charles T. Putman, Janka Hegedus · 2009 · Neurobiology of Disease
30. Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis
    Hong, Du, Zhang, Chi, Wu, Wenshuo, Lu, Xiaohui, Zhang, Liping · 2023 · Frontiers in Neurology
31. Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features
    Jennifer Marie Coughlin, Lindsay N. Hayes, Teppei Tanaka, Mei-Fang Xiao, Robert H. Yolken, Paul F. Worley, F. Markus Leweke, Akira Sawa · 2016 · Schizophrenia Research
32. Mutations in Superoxide Dismutase 1 (Sod1) Linked to Familial Amyotrophic Lateral Sclerosis Can Disrupt High-Affinity Zinc-Binding Promoted by the Copper Chaperone for Sod1 (Ccs)
    Stefanie D. Boyd, Morgan S. Ullrich, Jenifer S. Calvo, Fatemeh Behnia, Gabriele Meloni, Duane David Winkler · 2020 · Molecules
33. SOD1 Mutation Spectrum and Natural History of ALS Patients in a 15-Year Cohort in Southeastern China
    Luxi Chen, Haifeng Xu, Pei‐Shan Wang, Xin-Xia Yang, Zhi‐Ying Wu, Hong‐Fu Li · 2021 · Frontiers in Genetics
34. Loss of SOD1 and LYS7 Sensitizes Saccharomyces cerevisiae to Hydroxyurea and DNA Damage Agents and Downregulates MEC1 Pathway Effectors
    Carole D. Carter, Lauren E. Kitchen, Wei-Chun Au, Christopher M. Babic, Munira A. Basrai · 2005 · Molecular and Cellular Biology
35. Mechanism of pyroptosis in neurodegenerative diseases and its therapeutic potential by traditional Chinese medicine
    Yanfang Liao, Xue Wang, Liting Huang, Hu Qian, Wei Liu · 2023 · Frontiers in Pharmacology
36. CRISPR/Cas9 system and its applications in nervous system diseases
    Haibin Jiang, Meng-Yan Tang, Zidi Xu, Yanan Wang, Mopu Li, Shuyin Zheng, Jianghu Zhu, Zhenlang Lin, Min Zhang · 2023 · Genes & Diseases
37. High-content RNAi screening identifies the Type 1 inositol triphosphate receptor as a modifier of TDP-43 localization and neurotoxicity
    Sang Hwa Kim, Lihong Zhan, Keith A. Hanson, Randal S. Tibbetts · 2012 · Human Molecular Genetics
38. A Rare Motor Neuron Deleterious Missense Mutation in theDPYSL3(CRMP4) Gene is Associated with ALS
    Hélène Blasco, Nathalie Bernard‐Marissal, Patrick Vourc’h, Yves Olivier Guettard, Claire Sunyach, Olivier Augereau, Joelle Khederchah, Kévin Mouzat, Catherine Antar, Paul H. Gordon et al. · 2013 · Human Mutation
39. Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: a case-control study and literature review
    Qianqian Wei, Qingqing Zhou, Yongping Chen, Ruwei Ou, Bei Cao, Yaqian Xu, Jing Yang, Huifang Shang · 2017 · Scientific Reports
40. A Novel Leg-Shaking Drosophila Mutant Defective in a Voltage-Gated K+ Current and Hypersensitive to Reactive Oxygen Species
    Jing W. Wang, James M. Humphreys, John P. Phillips, Arthur J. Hilliker, Chun‐Fang Wu · 2000 · Journal of Neuroscience
41. Distal forearm fracture as risk factor for vertebral osteoporosis
    Nicola F. A. Peel, N. Ann Barrington, T W D Smith, Richard Eastell · 1994 · BMJ
42. Large-scale pathways-based association study in amyotrophic lateral sclerosis
    Dalia Kasperavičiūtė, Mike E. Weale, Kevin V. Shianna, Gareth T. Banks, Claire L. Simpson, Valerie K. Hansen, Martin R. Turner, Christopher E. Shaw, Ammar Al‐Chalabi, Hardev Pall et al. · 2007 · Brain
43. Prion Properties of SOD1 in Amyotrophic Lateral Sclerosis and Potential Therapy
    Caroline Sibilla, Anne Bertolotti · 2017 · Cold Spring Harbor Perspectives in Biology
44. Enhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies
    Bilal Khalil, Marie-Jeanne Cabirol, Laëtitia Miguel, Alexander J. Whitworth, Magalie Lecourtois, Jean-Charles Liévens · 2017 · Neurobiology of Aging
45. Adenosine A2A Receptors Activation Facilitates Neuromuscular Transmission in the Pre-Symptomatic Phase of the SOD1(G93A) ALS Mice, but Not in the Symptomatic Phase
    Filipe Nascimento, Paula A. Pousinha, Alexandra Marçal Correia, Rui Gomes, Ana Maria Sebastião, Joaquim Alexandre Ribeiro · 2014 · PLoS ONE
46. Amyotrophic Lateral Sclerosis with Anti-Acetylcholine Receptor Antibody.
    Yusuke OKUYAMA, Toshiki Mizuno, Hideki INOUE, Kunihiko Kimoto · 1997 · Internal Medicine
47. New considerations in the design of clinical trials for amyotrophic lateral sclerosis
    James D. Berry, Merit Cudkowicz · 2011 · Clinical Investigation
48. Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis
    Anna Tury, Kristine E. Tolentino, Yimin Zou · 2013 · Developmental Neurobiology
49. Male-Specific Differences in Proliferation, Neurogenesis, and Sensitivity to Oxidative Stress in Neural Progenitor Cells Derived from a Rat Model of ALS
    Ruojia Li, Rachel K. Strykowski, Michael Meyer, Patrick L. Mulcrone, Dan Krakora, Masatoshi Suzuki · 2012 · PLoS ONE
50. Measures of bulbar and spinal motor function, muscle innervation, and mitochondrial function in ALS rats
    Susan E. Smittkamp, Heather N. Spalding, Jordan W. Brown, Anisha A. Gupte, Jie Chen, Hiroshi Nishimune, Paige C. Geiger, John A. Stanford · 2010 · Behavioural Brain Research
51. Increased stem cell proliferation in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice
    Yingjun Guan, Xin Wang, Hong‐yan Wang, Kyutaro Kawagishi, Hoon Ryu, Chunfeng Huo, Ethan M. Shimony, Bruce S. Kristal, H. Georg Kuhn, Robert Max Friedlander · 2007 · Journal of Neurochemistry
52. Human Pluripotent Stem Cells: Applications and Challenges in Neurological Diseases
    Youssef Hibaoui, Anis Féki · 2012 · Frontiers in Physiology
53. Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone
    Jonathan A. Fidler, Christopher M. Treleaven, Ashley Frakes, Thomas J. Tamsett, Mary McCrate, Seng H. Cheng, Lamya S. Shihabuddin, Brian K. Kaspar, James C. Dodge · 2011 · The FASEB Journal
54. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis
    Florent Laferrière, Magdalini Polymenidou · 2015 · Swiss Medical Weekly
55. Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect
    Stephan Niemann · 2004 · Journal of Neurology Neurosurgery & Psychiatry
56. Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease
    Tiziana Bonifacino, Laura Musazzi, Marco Milanese, Mara Seguini, Antonella Marte, Elena Gallia, Luca Cattaneo, Franco Onofri, Maurizio Popoli, Giambattista Bonanno · 2016 · Neurobiology of Disease
57. A Genome-wide Expression Association Analysis Identifies Genes and Pathways Associated with Amyotrophic Lateral Sclerosis
    Yanan Du, Yan Fei Wen, Xiong Guo, Jingcan Hao, Wenyu Wang, Awen He, Qianrui Fan, Ping Li, Li Liu, Xiao Liang et al. · 2017 · Cellular and Molecular Neurobiology
58. The roles of the proteasome pathway in signal transduction and neurodegenerative diseases
    Jiaojiao Chen, Fang Lin, Zheng‐Hong Qin · 2008 · Neuroscience Bulletin
59. Discrete mitochondrial aberrations in the spinal cord of sporadic ALS patients
    Vedad Delic, Crupa Kurien, Josean Cruz, Sandra Zivkovic, Jennifer Barretta, Avery Thomson, Daniel Hennessey, Jaheem Joseph, Jared C. Ehrhart, Alison E. Willing et al. · 2018 · Journal of Neuroscience Research
60. The epidemiology of CuZn-SOD mutations in Germany: a study of 217 families
    Malessa Rabe, Ansgar Felbecker, Stefan Waibel, Peter J. Steinbach, Pia Winter, Albert Christian Ludolph · 2010 · Journal of Neurology
61. Participation in Physical Activity and Risk for Amyotrophic Lateral Sclerosis Mortality Among Postmenopausal Women
    Yvonne L. Eaglehouse, Evelyn O. Talbott, Yue‐Fang Chang, Lewis H. Kuller · 2016 · JAMA Neurology
62. Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
    Monica Nizzardo, C. Simoné, Federica Rizzo, Gianna Ulzi, Agnese Ramirez, Mafalda Rizzuti, Andreina Bordoni, Monica Bucchia, Stefano Gatti, Nereo Bresolin et al. · 2016 · Scientific Reports
63. Sigma-1 receptor is a key genetic modulator in amyotrophic lateral sclerosis
    Simon Couly, Bilal Khalil, Véronique Viguier, Julien Roussel, Tangui Maurice, Jean-Charles Liévens · 2019 · Human Molecular Genetics
64. Mutation spectrum of amyotrophic lateral sclerosis in Central South China
    Zhen Liu, Yanchun Yuan, Mengli Wang, Jie Ni, Wanzhen Li, Ling Huang, Yiting Hu, Pan Liu, Xiaorong Hou, Xuan Hou et al. · 2021 · Neurobiology of Aging
65. Disturb mitochondrial associated proteostasis: Neurodegeneration and imperfect ageing
    Yuvraj Anandrao Jagtap, Prashant Kumar, Sumit Kinger, Ankur Rakesh Dubey, Akash Choudhary, Ravi Kumar Gutti, Sarika Singh, Hem Chandra Jha, Krishna Mohan Poluri, Amit Mishra · 2023 · Frontiers in Cell and Developmental Biology
66. Sirtuin Deacetylases as Therapeutic Targets in the Nervous System
    Brett C. Langley, Anthony A. Sauve · 2013 · Neurotherapeutics
67. Association of Skin with the Pathogenesis and Treatment of Neurodegenerative Amyloidosis
    Audra L. Clos, Rakez Kayed, Cristian A. Lasagna‐Reeves · 2012 · Frontiers in Neurology
68. Amyotrophic lateral sclerosis: one or multiple causes?
    Aline Furtado Bastos, Marco Antônio Orsini, Dionis de Castro Dutra Machado, Mariana Pimentel de Mello, Sergio Nader, Júlio Guilherme Silva, Antônio Marcos da Silva Catharino, Víctor Hugo Bastos, Alessandra Pereira, Luciane Lacerda de Oliveira Pessôa et al. · 2011 · Neurology International
69. Differential gene expression in a cell culture model of SOD1-related familial motor neurone disease
    Janine Kirby · 2002 · Human Molecular Genetics
70. Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity
    Pamela McCombe, Naomi R. Wray, Robert D. Henderson · 2016 · Expert Review of Neurotherapeutics
71. A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies
    Abigail DeLoach, Michael A. Cozart, Arianna Kiaei, Mahmoud Kiaei · 2015 · Expert Opinion on Drug Discovery
72. Identification of mutations in Korean patients with amyotrophic lateral sclerosis using multigene panel testing
    Hee-Jung Kim, Ki‐Wook Oh, Min‐Jung Kwon, Seong‐il Oh, Jinseok Park, Young-Eun Kim, Byung‐Ok Choi, Seungbok Lee, Chang‐Seok Ki, Seung Hyun Kim · 2015 · Neurobiology of Aging
73. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model
    Zichun Zhao, Yanling Sui, Wenchao Gao, Bin Cai, Dongsheng Fan · 2014 · Journal of International Medical Research
74. Loss of Vps54 Function Leads to Vesicle Traffic Impairment, Protein Mis-Sorting and Embryonic Lethality
    Páll Karlsson, Aida Droce, Jakob Moser, Simon Cuhlmann, Carolina Padilla, Peter Heimann, Jörg Walter Bartsch, Annette Christine Füchtbauer, Ernst‐Martin Füchtbauer, Thomas Schmitt‐John · 2013 · International Journal of Molecular Sciences
75. Mutational analysis of the Cu/Zn superoxide dismutase gene in 23 familial and 69 sporadic cases of amyotrophic lateral sclerosis in Belgium
    Tania Aguirre, Gert Matthijs, Wim Robberecht, Petra Tilkin, Jean‐Jacques Cassiman · 1999 · European Journal of Human Genetics
76. 50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis
    Wendy J. Broom, Matthew J. Greenway, Ghazaleh Sadri‐Vakili, Carsten Russ, Kristen E. Auwarter, Kelly E. Glajch, Nicolas Dupré, Robert J Swingler, Shaun Purcell, Caroline Hayward et al. · 2008 · Amyotrophic Lateral Sclerosis
77. RNAi knockdown of Par‐4 inhibits neurosynaptic degeneration in ALS‐linked mice
    Jun Xie, Keytam S. Awad, Qing Guo · 2004 · Journal of Neurochemistry
78. S-nitrosylation of the thioredoxin-like domains of protein disulfide isomerase and its role in neurodegenerative conditions
    Myra E. Conway, Matthew Harris · 2015 · Frontiers in Chemistry
79. Thrombin and the Coag-Inflammatory Nexus in Neurotrauma, ALS, and Other Neurodegenerative Disorders
    Barry W. Festoff, Bruce A. Citron · 2019 · Frontiers in Neurology
80. Hippo signaling: bridging the gap between cancer and neurodegenerative disorders
    Amit Singh, Neha Gogia, Anuradha Venkatakrishnan Chimata, Prajakta Deshpande, Aditi Singh · 2020 · Neural Regeneration Research
81. A copper chaperone–mimetic polytherapy for SOD1-associated amyotrophic lateral sclerosis
    Luke McAlary, Victoria K. Shephard, Gareth S. A. Wright, Justin J. Yerbury · 2022 · Journal of Biological Chemistry
82. In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model
    Yi A. Chen, Mark W. Kankel, Sam Hana, Shukkwan Kelly Lau, Maria I. Zavodszky, Olivia P. McKissick, Nicole Mastrangelo, Jessica Dion, Bin Wang, Daniel Ferretti et al. · 2022 · Gene Therapy
83. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis
    Smriti Sangwan, David S Eisenberg · 2016 · Postępy Biochemii
84. Clinical and genetic features of patients with amyotrophic lateral sclerosis in southern China
    W. Chen, Yulei Xie, Min Zheng, Jianing Lin, Pinbo Huang, Zishuo Pei, Xiaoli Yao · 2020 · European Journal of Neurology
85. SIRT1/PGC-1
    Soumya Rasouri, Marie Lagouge, Johan H. Auwerx · 2007 · médecine/sciences
86. Oxidative injury is present in Purkinje cells in patients with olivopontocerebellar atrophy
    Taro Yamashita, Yukio Ando, Konen Obayashi, Hisayasu Terazaki, Naomi Sakashita, Kôji Uchida, Esaku Ohama, Masayuki Ando, Makoto Uchino · 2000 · Journal of the Neurological Sciences
87. Gene Therapy for ALS: Progress and prospects
    Mimoun Azzouz · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
88. Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission
    Filipe Nascimento, Ana Maria Sebastião, Joaquim Alexandre Ribeiro · 2015 · Purinergic Signalling
89. The Role and Therapeutic Potential of the Integrated Stress Response in Amyotrophic Lateral Sclerosis
    Elías Marlin, Cristina Viu-Idocin, Montserrat Arrasate, Tomás Aragón · 2022 · International Journal of Molecular Sciences
90. Ultrastructural features of aberrant glial cells isolated from the spinal cord of paralytic rats expressing the amyotrophic lateral sclerosis-linked SOD1G93A mutation
    Marcie Jiménez, Pablo Díaz‐Amarilla, Eugenia Isasi, Gabriela Casanova, Luis Barbeito, Silvia Olivera‐Bravo · 2017 · Cell and Tissue Research
91. Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF (cyclin F) complex
    Albert Lee, Stephanie L. Rayner, Alana De Luca, Serene S. L. Gwee, Marco Morsch, Vinod Sundaramoorthy, Hamideh Shahheydari, Audrey Ragagnin, Bingyang Shi, Shu Yang et al. · 2017 · Open Biology
92. Retrograde axonal transport of neurotrophins: Differences between neuronal populations and implications for motor neuron disease
    Selena E. Bartlett, Anna J. Reynolds, Ian A. Hendry · 1998 · Immunology and Cell Biology
93. Protective effects of EVs/exosomes derived from permanently growing human MSC on primary murine ALS motor neurons
    Thomas Gschwendtberger, Nadine Thau‐Habermann, Juliane von der Ohe, Tianjiao Luo, Ralf Hass, Susanne Petri · 2023 · Neuroscience Letters
94. Oxidative injury in multiple sclerosis cerebellar grey matter
    Kevin C. Kemp, Juliana Redondo, Kelly M Hares, Claire M Rice, Neil J. Scolding, Alastair Wilkins · 2016 · Brain Research
95. Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis
    Guillem Mòdol‐Caballero, Belén García-Lareu, Sergi Verdés, Lorena Ariza, Irene Sánchez-Brualla, Frédéric Brocard, Assumpció Bosch, Xavier Navarro, Mireia Herrando‐Grabulosa · 2020 · Neurotherapeutics
96. NEK1 mutations and the risk of amyotrophic lateral sclerosis (ALS): a meta-analysis
    Luqing Yao, Xiaoyan He, Baolong Cui, Fang Zhao, Chang Zhou · 2021 · Neurological Sciences
97. Mechanical Probes of SOD1 Predict Systematic Trends in Metal and Dimer Affinity of ALS-Associated Mutants
    Atanu Das, Steven Samuel Plotkin · 2013 · Journal of Molecular Biology
98. Immunohistochemical Observation of Canine Degenerative Myelopathy in Two Pembroke Welsh Corgi Dogs
    Ogawa Mizue, Kazuyuki Uchida, Eunsil Park, Hiroaki Kamishina, Jun Sasaki, Hye-Sook Chang, Osamu Yamato, Hiroyuki Nakayama · 2011 · Journal of Veterinary Medical Science
99. Low Ca2+ buffering in hypoglossal motoneurons of mutant SOD1 (G93A) mice
    Friederike von Lewinski, Julia Fuchs, Bodo Karsten Vanselow, Bernhard U. Keller · 2008 · Neuroscience Letters
100. Neuroprotection for Amyotrophic Lateral Sclerosis: Role of Stem Cells, Growth Factors, and Gene Therapy
     Rachna S. Pandya, Lilly L. J. Mao, Edward Zhou, Robert P. Bowser, Zhenglun Zhu, Yongjin Zhu, Xin Wang · 2012 · Central Nervous System Agents in Medicinal Chemistry